|
A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance Clinical research trials and A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance. A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance clinical trial. Participants oftentimes recieve the finest healthcare available for their A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance
A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance
For Condition: Tuberculosis
Status: No longer recruiting
Sponsor(s): Centers for Disease Control and Prevention , Department of Veterans Affairs
Synopsis: Primary Objective: To evaluate the efficacy of a directly-observed, largely-intermittent, six-month regimen of rifampin, pyrazinamide, ethambutol among patients with culture confirmed isoniazid-resistant M. tuberculosis. Secondary Objectives: To describe the rate, severity and timing of toxicities and drug intolerances associated with this treatment regimen. To describe the utility of this regimen among patients who are unable to continue the standard 4-drug regimen due to the development of intolerance to isoniazid
Details:
Eligibility:
Study Type: Interventional, Treatment, Efficacy Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: - Patients with culture-confirmed isoniazid-resistant M. tuberculosis
Total Enrollment:
Location and Contact Information:
Hines VA Medical Center
Hines, Illinois, 60141
United States
University of North Texas Health Science Center
Ft. Worth, Texas, 76107-2699
United States
University of British Columbia
Vancouver, British Columbia, Canada V5Z 4R4
Canada
University of Manitoba
Winnipeg, Manitoba, CANADA R3A 1R8
Canada
Nashville VA Medical Center
Nashville, Tennessee, 37212-2637
United States
LA County/USC Medical Center
Los Angeles, California, 90033
United States
Seattle King County Health Department
Seattle, Washington, 98104
United States
Boston Medical Center
Boston, Massachusetts, 02118
United States
Denver Department of Public Health and Hospitals
Denver, Colorado, 80204
United States
Montreal Chest Institute McGill University
Montreal, Quebec, H2X 2P4Pq Canada
Canada
Washington, D.C. VAMC
Washington D.C., District of Columbia, 20422
United States
Chicago VA Medical Center (Lakeside)
Chicago, Illinois, 60611
United States
New Jersey Medical School
Newark, New Jersey, 07107-3001
United States
New York University School of Medicine
New York City, New York, 10016
United States
Columbia University/Presbyterian Medical Center
New York City, New York, 10032
United States
Duke University Medical Center
Durham, North Carolina, 34222
United States
Harlem Hospital Center
New York City, New York, 10037
United States
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287-0003
United States
Audi L. Murphy VA Hospital
San Antonio, Texas, 78284
United States
Central Arkansas Veterans Health System
Little Rock, Arkansas, 72205
United States
Carolinas Medical Center
Charlotte, North Carolina, 28203
United States
Thomas Street Clinic
Houston, Texas, 77009
United States
University of California, San Francisco
San Francisco, California, 94110
United States
Additional Information:
Study ID Numbers: 2340; 24
Study Start Date:
Record last reviewed: February 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00023374
Other Tuberculosis Studies:
1. A Study of the Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for Three Months Versus Daily Isoniazid for Nine Months for the Treatment of Latent Tuberculosis Infection
2. Pilot Study to Evaluate Nucleic Acid Amplification Methods in the Diagnosis and Management of Active TB
3. Tuberculosis in HIV Infected Patients in Uganda
4. Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz
5. Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients with HIV-Related Tuberculosis Treated with a Rifabutin-Based Regimen
Related Studies:
Other Tuberculosis Clinical Trials
Other British Columbia Clinical Trials
Other Vancouver Clinical Trials
A Non-Comparative Study of the Efficacy of a Largely-Intermittent, Six-Month Tuberculosis Treatment Regimen Among Patients Who Will Not Receive Isoniazid Due to Initial Isoniazid Resistance or Intolerance
|
|
|
|
|
|
|
|